NRAS and melanoma: Even though at different extend, increasing concentrations of each EO displayed a similar ability in significantly reducing the viability of both BRAF wild type/NRAS mutant (Sbcl1, ME4405), BRAF wild type/NRAS wild type (ME1007), and BRAF mutant/NRAS wild type (M14, A375, LOX IMVI) melanoma cells (Fig. 2a–f, Fig. S1c), thus indicating the absence of relevance of BRAF or NRAS status in the sensitivity to EOs.